<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3006290/" ref="ordinalpos=4435&amp;ncbi_uid=3592110&amp;link_uid=PMC3006290" image-link="/pmc/articles/PMC3006290/figure/F1/" class="imagepopup">Fig. 1. From: Cardioprotective PKG-independent NO <span class="highlight" style="background-color:">signaling</span> at reperfusion. </a></div><br /><div class="p4l_captionBody">Proposed signaling scheme for ischemic preconditioning. Note that in the schematic, nitric oxide synthase (NOS) signals through protein kinase G (PKG) upstream in the trigger pathway but acts in a PKG-independent manner downstream in the mediator pathway at reperfusion. The role of glycogen synthase kinase-3β (GSK-3β) is controversial, but if it is in the pathway, then it must be downstream of the newly described NOS site. AR, adenosine receptor; PI3-K, phosphatidylinositol 3-kinase; PLC, phospholipase C; PLD, phospholipase D; ERK, extracellular signal-regulated kinase; GC, guanylyl cyclase; PKC, protein kinase C; mKATP, mitochondrial ATP-dependent K+ channel; mPTP, mitochondrial permeability transition pore; RISK, reperfusion injury survival kinases.</div></div>